Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 2,444 |
|
|||||
| News | - | ||||||
| Day High | 1.45 | Low High |
|||||
| Day Low | 1.35 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| HCW Biologics Inc | HCWB | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0601 | -4.12% | 1.3999 | 17:16:11 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.45 | 1.35 | 1.45 | 1.3999 | 1.46 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 39 | 2,444 | $ 1.39 | $ 3,388 | - | 0.91 - 2.32 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 2 | $ 1.39 | USD |
HCW Biologics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 50.36M | 35.97M | - | 2.84M | -24.99M | -0.69 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
HCW Biologics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HCWB Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.55 | 1.64 | 1.35 | 1.57 | 3,420 | -0.1501 | -9.68% |
| 1 Month | 1.71 | 1.93 | 1.35 | 1.64 | 7,159 | -0.3101 | -18.13% |
| 3 Months | 1.18 | 1.93 | 1.10 | 1.54 | 16,379 | 0.2199 | 18.64% |
| 6 Months | 1.8808 | 1.93 | 0.91 | 1.40 | 17,034 | -0.4809 | -25.57% |
| 1 Year | 1.31 | 2.32 | 0.91 | 1.62 | 14,995 | 0.0899 | 6.86% |
| 3 Years | 7.50 | 7.51 | 0.91 | 4.43 | 306,558 | -6.10 | -81.33% |
| 5 Years | 7.50 | 7.51 | 0.91 | 4.43 | 306,558 | -6.10 | -81.33% |
HCW Biologics Description
| HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. |
